Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M246Revenue $M284Net Margin (%)-70.7Z-Score-7.3
Enterprise Value $M704EPS $-2.0Operating Margin %-52.4F-Score4
P/E(ttm))0Cash Flow Per Share $-1.6Pre-tax Margin (%)-17.6Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %5.9Quick Ratio2.3Cash flow > EarningsY
Price/Sales0.85-y EBITDA Growth Rate %-10.6Current Ratio3.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-56.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M160ROI % (ttm)-61.2Gross Margin Increase y-yY

Gurus Latest Trades with DNDN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
DNDNJohn Burbank 2012-09-30 Sold Out -0.13%$4.27 - $7.43
$ 1.51-72%Sold Out0
DNDNPRIMECAP Management 2012-09-30 Reduce-0.02%$4.27 - $7.43
$ 1.51-72%Reduce -28.95%4,427,800
DNDNPRIMECAP Management 2012-06-30 Reduce-0.04%$5.83 - $11.8
$ 1.51-82%Reduce -28.51%6,231,930
DNDNJohn Burbank 2012-03-31 Buy 0.18%$7.6 - $16.53
$ 1.51-87%New holding, 500000 sh.500,000
DNDNGeorge Soros 2011-12-31 Sold Out -0.03%$6.55 - $11.29
$ 1.51-82%Sold Out0
DNDNGeorge Soros 2011-09-30 Reduce-1.33%$9.12 - $41.64
$ 1.51-93%Reduce -92.85%185,000
DNDNGeorge Soros 2011-06-30 Reduce-1.22%$36.86 - $43.43
$ 1.51-96%Reduce -44.64%2,586,366
DNDNGeorge Soros 2011-03-31 Add0.21%$31.85 - $38.2
$ 1.51-96%Add 11.27%4,671,699
DNDNPRIMECAP Management 2011-03-31 Add0.08%$31.85 - $38.2
$ 1.51-96%Add 26.03%7,544,649
DNDNGeorge Soros 2010-12-31 Add1.08%$33.84 - $41.22
$ 1.51-96%Add 131.15%4,198,696
DNDNGeorge Soros 2010-09-30 Buy 1.12%$27.31 - $42.58
$ 1.51-96%New holding, 1816463 sh.1,816,463
DNDNGeorge Soros 2010-06-30 Sold Out -0.01%$33.59 - $55.43
$ 1.51-96%Sold Out0
DNDNGeorge Soros 2010-03-31 Buy 0.01%$26.28 - $37.818
$ 1.51-95%New holding, 11938 sh.11,938
DNDNPRIMECAP Management 2009-09-30 Add0.06%$22.13 - $29.46
$ 1.51-94%Add 32.23%4,554,500
DNDNPRIMECAP Management 2009-06-30 Add0.08%$4.14 - $26.08
$ 1.51-92%Add 88.15%3,444,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DNDN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DNDN PRIMECAP Management 2014-06-302,901,8001.810.01-5.47%
Premium Most recent portfolio changes are included for Premium Members only!

DNDN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rocco LindsayEVP, Corporate Communications 2013-12-10Sell8,207$2.94-53.4view
CANET GERARDODirector 2012-08-01Buy10,000$4.38-68.72view
Frohlich Mark WSee Remarks 2012-04-23Sell2,687$10.56-87.03view
Frohlich Mark WSee General Remarks 2012-01-23Sell3,230$13.24-89.65view
BAYH SUSAN BDirector 2011-09-09Buy20,000$11.05-87.6view
GOLD MITCHELLPresident & Chief Executive Of 2011-07-25Sell19,000$38.37-96.43view
Frohlich Mark WSee General Remarks 2011-07-21Sell3,230$39.13-96.5view
URDAL DAVIDSVP, Chief Scientific Officer 2011-07-21Sell1,015$38.75-96.46view
URDAL DAVIDSVP, Chief Scientific Officer 2011-07-17Sell7,347$38.98-96.49view
GOLD MITCHELLPresident & Chief Executive Of 2011-06-27Sell19,000$38.69-96.46view

Press Releases about DNDN :

    Quarterly/Annual Reports about DNDN:

    News about DNDN:

    Articles On GuruFocus.com
    A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio Aug 15 2014 
    Why You Should Buy Dendreon's Drop Jul 19 2014 
    An Ocean of 52-Week Lows - 50% Off High, Second Quarter Financials Aug 11 2013 
    Idenix: Strong Pipeline Will Reward Investors Apr 24 2012 
    Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
    Dendreon Could Slip On Shrinking Market For Provenge Apr 22 2012 
    Weekly Guru Bargains Highlights: DNDN, AUQ, RFMD, PT, INFA Jan 16 2012 
    Weekly Guru Bargains Highlights: FTR, HUN, HFC, DNDN, PEGA Jan 09 2012 
    Options III: Strategy for the Long Term - Writing Covered Calls Oct 17 2011 
    Thursday Value Overview Aug 04 2011 

    More From Other Websites
    Bumpy Market Got You Stressed? Try The Smooth Stylings of Kenny G: Stockpicker Sep 12 2014
    Medivation Eyes Blockbuster As Cancer Drug Gets An OK Sep 11 2014
    Two Portfolios. Pick One. Aug 29 2014
    DENDREON CORP Financials Aug 19 2014
    Dendreon Down on Default Risk, Reports Narrower Q2 Loss Aug 13 2014
    Dendreon downgraded by R. F. Lafferty Aug 13 2014
    Is an Impending Implosion of Dendreon Avoidable? Aug 12 2014
    Dendreon Shares Plunge on Concern Debt Won't Be Repaid Aug 12 2014
    Two drug makers diverge in Wall Street woods, and see huge moves Aug 12 2014
    Why Dendreon (DNDN) Stock Hit a One-Year Low Today Aug 12 2014
    [video] The Top Ten Stocks for Tuesday, August 12 Aug 12 2014
    Dendreon's Debt Problem: Mulls Wiping Out Shareholders Aug 12 2014
    Dendreon shares tumble after company warns of default risk Aug 12 2014
    Dendreon Warns Debt Bomb Might Wipe Out Shareholders Aug 12 2014
    DENDREON CORP Files SEC form 10-Q, Quarterly Report Aug 11 2014
    DENDREON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jul 30 2014
    Dendreon Names W. Thomas Amick President and Chief Executive Officer Jul 30 2014
    3 Convincing Reasons To Buy Dendreon Jul 24 2014
    New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May Jul 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    ReplyBigJake - 2 weeks ago
    debt and bad management have destroyed a young company with a great drug. Will look to see if they emerge from impending bankruptcy
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial